Concepedia

Lisa Kamen

LK

4

Publications

1K

Citations

4

H-Index

2009

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Otsuka (United States)

Bristol-Myers Squibb (Germany)

Lisa Kamen is an author at Bristol-Myers Squibb (United States) specializing in pharmacotherapy, medicine, and neurology.

Top concepts

Publications per year

2009–2020

4

Publications

4

A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder

Ronald N. Marcus, Randall Owen, Lisa Kamen et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2009 · 539 citations

, , +11

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

Robert Croop, Richard B. Lipton, David Kudrow et al. · The Lancet · 2020 · 334 citations

, , +7

Safety and Tolerability of Aripiprazole for Irritability in Pediatric Patients With Autistic Disorder

Ronald N. Marcus, Randall Owen, George Manos et al. · The Journal of Clinical Psychiatry · 2011 · 89 citations

Aripiprazole in the Treatment of Irritability in Pediatric Patients (Aged 6–17 Years) with Autistic Disorder: Results from a 52-Week, Open-Label Study

Ronald N. Marcus, Randall Owen, George Manos et al. · Journal of Child and Adolescent Psychopharmacology · 2011 · 77 citations

Rows per page

1–4 of 4